Medicine and Dentistry
Adverse Event
11%
Angiopeptin
20%
Antibody Response
12%
Autosomal Dominant Inheritance
8%
Awareness
8%
B Cell
8%
Biological Marker
10%
Case-Control Study
8%
Cellular Immunity
8%
Chronic Kidney Disease
59%
Cohort Study
8%
COVID-19
33%
COVID-19 Vaccination
40%
COVID-19 Vaccine
21%
Cross Sectional Study
9%
Disease
9%
Disease Exacerbation
36%
Disease Severity
8%
Glomerular Filtration Rate
20%
Immune Response
12%
Immunogenicity
17%
Immunoglobulin G Antibody
20%
Immunosuppressive Treatment
8%
Infusion
9%
Interleukin 21
8%
Kidney Function
36%
Kidney Graft
88%
Kidney Transplantation
8%
Magnetic Resonance Imaging
16%
mRNA Vaccine
8%
Mycophenolic Acid
20%
Nephropathy
20%
Observational Study
9%
Oxidative Stress
8%
Polycystic Kidney Disease
100%
Polyuria
8%
Post-Hoc Analysis
8%
Randomized Clinical Trial
18%
Renal Physiology
8%
Renal Replacement Therapy
12%
Seroconversion
9%
Severe Acute Respiratory Syndrome Coronavirus 2
53%
Somatostatin
16%
T-Cell Response
18%
Thiol
8%
Tolvaptan
18%
Torque Teno Virus 1
8%
Ureter
8%
Urinary System
9%
Vasopressin V2 Receptor
11%
Keyphrases
Antibody Formation
9%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
83%
B Cells
8%
Chronic Kidney Disease
16%
Chronic Kidney Disease Stage
13%
COVID-19
31%
COVID-19 Vaccination
18%
Dialysis
20%
Disease Progression
29%
Disease Severity
8%
Dutch
12%
Egfr
8%
Estimated Glomerular Filtration Rate
19%
Free Thiols
8%
Gastrointestinal Diseases
8%
Hepatic Cyst Infection
9%
Humoral Response
13%
IgG Antibody Titer
8%
Kidney Disease
10%
Kidney Disease Progression
18%
Kidney Function
14%
Kidney Patients
16%
Kidney Transplant
8%
Kidney Transplant Recipients
49%
Kidney Volume
13%
Lanreotide
20%
Liver Growth
8%
Liver Volume
16%
Living Kidney Donor
8%
Living with
8%
Mycophenolic Acid
10%
Netherlands
9%
Patients with Kidney Disease
9%
Preventive Measures
8%
Randomized Clinical Trial
9%
Reference Network
8%
Renal Functional Reserve
8%
Risk Markers
9%
SARS-CoV-2 Spike
10%
SARS-CoV-2 Vaccination
22%
Somatostatin
16%
T Helper 1
8%
T2-weighted Magnetic Resonance Imaging
8%
Tolvaptan
10%
Total Kidney Volume
26%
Total Liver Volume
8%
Treatment Selection
9%
Vaccination
18%
Vaccine Research
9%
Vaccine Response
16%
Immunology and Microbiology
Adoptive Immunity
8%
Autosomal Dominant Inheritance
8%
B Cell
8%
Beta-2 Microglobulin
5%
COVID-19
61%
Cytokine
9%
Cytokine Response
8%
Humoral Immunity
11%
Immune Response
13%
Immunogenicity
8%
Immunoglobulin G Antibody
20%
Immunosuppressive Drug
8%
Interleukin 21
8%
Mycophenolic Acid
18%
Receptor Binding
8%
Seroconversion
9%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
T Cell
13%
Torque Teno Virus 1
8%
Transplant Procedure
64%
Vaccination Policy
67%
Vaccine Efficacy
23%
Viral Load
8%
